相关实验视频

Updated: Jan 10, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

BST2通过巨细胞M2极化,神经重塑和免疫抑制微环境形成驱动上皮卵巢癌的进展

Limin Zhang^1,2,3, Xiaoli Huang^2,3, Shaoyu Wang^2,3

¹College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.

|November 24, 2025

概括

骨髓流体抗原2 (BST2) 促进了上皮卵巢癌 (EOC) 的进展,并影响了巨细胞的两极分化. BST2表达水平可以作为EOC患者的预后标记,表明BST2是潜在的免疫治疗点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

表皮卵巢癌 (EOC) 是妇科癌症死亡率的主要原因.
目前的治疗干预措施为EOC的生存率提供了有限的改善.
新的治疗目标对于提高EOC患者生存结果至关重要.

研究的目的:

调查骨髓流体抗原2 (BST2) 在EOC病变发生过程中的作用.
在EOC的背景下,探索BST2对巨细胞极化的影响.
评估BST2作为EOC免疫治疗的潜在目标.

主要方法:

使用TCGA基因表达和以BST2.2为中心的临床数据开发了EOC的预后模型.
在HGSOC细胞系中,使用RT-qPCR和西白斑测量了BST2表达的数量.
通过基因沉默和过度表达来评估BST2对EOC细胞增殖,迁移和入侵的功能影响.

主要成果:

在EOC组织中增加BST2表达与更差的预后指标相关.
增加BST2表达增强了EOC细胞的生长,运动性和侵入性.
BST2调制改变了卵巢瘤中的巨细胞表型,影响了瘤的进展.

结论:

BST2被确定为卵巢癌进展的关键促进者.
BST2表达水平显示出作为EOC患者结果的预后标志物的潜力.
准BST2,包括其调节巨细胞极化,为EOC免疫疗法提供了一个有前途的途径.

关键词:

在 BST2 中, BST2 是上皮卵巢癌卵巢癌卵巢癌巨细胞是什么?巨细胞是什么?神经元神经元的神经元

更多相关视频

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Transplantation Into the Mouse Ovarian Fat Pad

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...